Literature DB >> 15772919

Determinants of hospitalization in a cohort of chronic dialysis patients in central Italy.

Anteo Di Napoli1, Patrizio Pezzotti, Domenico Di Lallo, Valeria Tancioni, Paolo Papini, Gabriella Guasticchi.   

Abstract

BACKGROUND: Few studies linking hospital discharge records with the population register of chronic dialysis (CD) patients are available. This study aimed to evaluate the frequency and the determinants of hospitalization, taking into account the demographic, clinical and biochemical data.
METHODS: We conducted a retrospective cohort study in 3411 patients starting dialysis from 1996-2000, reported to the Lazio Dialysis Registry (RDL) (Italy). These patients were linked with the hospital information system from 1996-2002. Hospital admission probability was calculated using the Kaplan-Meier method. To evaluate the determinants of hospitalization risk we used Cox's proportional hazards for the first admission and a marginal model considering competitive effect of mortality, the Wei-Lin-Weissfeld model, for any admission.
RESULTS: We found 7530 hospital admissions, referring to 1711 patients (50.7%), with a rate of 63/100 person-years. The most prevalent diagnoses were "diseases of the genitourinary system", (37.4%), and "diseases of the circulatory system", among secondary diagnoses (46.6%). Hospitalization probability was 34.4% at 1 yr after starting dialysis. The risk of first and any hospital admission was higher (p<0.05) for patients having more than one comorbid disease, hematocrit (Hct) level <30%, serum albumin level <3.5 g/dL, and a low degree of self-sufficiency.
CONCLUSIONS: Hospitalization frequency, mainly during the first months of dialysis, suggests the need to improve the early management of chronic renal failure and indicates the importance of preventing complications and maximizing functional status among the dialysis population.

Entities:  

Mesh:

Year:  2005        PMID: 15772919

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  7 in total

Review 1.  Reducing hospital readmissions in patients with end-stage kidney disease.

Authors:  Anna T Mathew; Giovanni F M Strippoli; Marinella Ruospo; Steven Fishbane
Journal:  Kidney Int       Date:  2015-10-14       Impact factor: 10.612

2.  Functional impairment and risk of mortality in patients on chronic hemodialysis: results of the Lazio Dialysis Registry.

Authors:  Maurizio Bossola; Claudia Marino; Anteo Di Napoli; Nera Agabiti; Luigi Tazza; Marina Davoli
Journal:  J Nephrol       Date:  2018-03-23       Impact factor: 3.902

3.  Strategies to Reduce Rehospitalization in Patients with CKD and Kidney Failure.

Authors:  Simit Doshi; Jay B Wish
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 8.237

4.  Early and late mortality in elderly patients after hip fracture: a cohort study using administrative health databases in the Lazio region, Italy.

Authors:  Esmeralda Castronuovo; Patrizio Pezzotti; Antonella Franzo; Domenico Di Lallo; Gabriella Guasticchi
Journal:  BMC Geriatr       Date:  2011-08-05       Impact factor: 3.921

5.  Incidence and risk factors of hospitalization for bronchiolitis in preterm children: a retrospective longitudinal study in Italy.

Authors:  Patrizio Pezzotti; Jessica Mantovani; Nicoletta Benincori; Eleonora Mucchino; Domenico Di Lallo
Journal:  BMC Pediatr       Date:  2009-09-10       Impact factor: 2.125

6.  Potentially Avoidable Readmissions in United States Hemodialysis Patients.

Authors:  Anna T Mathew; Lisa Rosen; Renee Pekmezaris; Andrzej Kozikowski; Daniel W Ross; Thomas McGinn; Kamyar Kalantar-Zadeh; Steven Fishbane
Journal:  Kidney Int Rep       Date:  2017-11-03

7.  Ten-year experience of an outpatient clinic for CKD-5 patients with multidisciplinary team and educational support.

Authors:  Vincenzo Terlizzi; Massimo Sandrini; Valerio Vizzardi; Mattia Tonoli; Annalisa Facchini; Luigi Manili; Letizia Zeni; Giovanni Cancarini
Journal:  Int Urol Nephrol       Date:  2021-07-31       Impact factor: 2.370

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.